glp-1 ed Researchers Explore Possible Link Between Drugs and Erectile Dysfunction Managing Side Effects of GLP-1

Madeo et al., 2019

Principal Investigator on A Randomized, Double-blind, Multicentre, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy. Principal Investigator on A Study of Disease Characteristics and Real-life Standard of Care Effectiveness in Patients with Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including an SSRI or SNR. (Janssen)

aHR: 0.88, 95% CI: 0.800.96) and MAKEs (10.8% vs

Beneficial effects of growth hormone treatment in GH-deficient adults